192 related articles for article (PubMed ID: 19022537)
1. Synthesis, anti-tuberculosis activity and 3D-QSAR study of amino acid conjugates of 4-(adamantan-1-yl) group containing quinolines.
Nayyar A; Patel SR; Shaikh M; Coutinho E; Jain R
Eur J Med Chem; 2009 May; 44(5):2017-29. PubMed ID: 19022537
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents.
Nayyar A; Malde A; Jain R; Coutinho E
Bioorg Med Chem; 2006 Feb; 14(3):847-56. PubMed ID: 16214351
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents.
Patel SR; Gangwal R; Sangamwar AT; Jain R
Eur J Med Chem; 2015 Mar; 93():511-22. PubMed ID: 25747550
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, anti-tubercular activity and 3D-QSAR study of coumarin-4-acetic acid benzylidene hydrazides.
Manvar A; Malde A; Verma J; Virsodia V; Mishra A; Upadhyay K; Acharya H; Coutinho E; Shah A
Eur J Med Chem; 2008 Nov; 43(11):2395-403. PubMed ID: 18328603
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents.
Patel SR; Gangwal R; Sangamwar AT; Jain R
Eur J Med Chem; 2014 Oct; 85():255-67. PubMed ID: 25089809
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of ring-substituted-2/4-quinolinecarbaldehyde derivatives.
Nayyar A; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2006 Nov; 14(21):7302-10. PubMed ID: 16843663
[TBL] [Abstract][Full Text] [Related]
8. Screening for in vitro antimycobacterial activity and three-dimensional quantitative structure-activity relationship (3D-QSAR) study of 4-(arylamino)coumarin derivatives.
Virsdoia V; Shaikh MS; Manvar A; Desai B; Parecha A; Loriya R; Dholariya K; Patel G; Vora V; Upadhyay K; Denish K; Shah A; Coutinho EC
Chem Biol Drug Des; 2010 Nov; 76(5):412-24. PubMed ID: 20925693
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and 3D-QSAR analysis of 2-chloroquinoline derivatives as H37 RV MTB inhibitors.
Khunt RC; Khedkar VM; Coutinho EC
Chem Biol Drug Des; 2013 Dec; 82(6):669-84. PubMed ID: 23790070
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides.
Virsodia V; Pissurlenkar RR; Manvar D; Dholakia C; Adlakha P; Shah A; Coutinho EC
Eur J Med Chem; 2008 Oct; 43(10):2103-15. PubMed ID: 17950956
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.
Aparna V; Jeevan J; Ravi M; Desiraju GR; Gopalakrishnan B
Bioorg Med Chem Lett; 2006 Feb; 16(4):1014-20. PubMed ID: 16290929
[TBL] [Abstract][Full Text] [Related]
12. Development of CoMFA, advance CoMFA and CoMSIA models in pyrroloquinazolines as thrombin receptor antagonist.
Dixit A; Kashaw SK; Gaur S; Saxena AK
Bioorg Med Chem; 2004 Jul; 12(13):3591-8. PubMed ID: 15186843
[TBL] [Abstract][Full Text] [Related]
13. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators.
Globisch C; Pajeva IK; Wiese M
Bioorg Med Chem; 2006 Mar; 14(5):1588-98. PubMed ID: 16307883
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.
Upadhayaya RS; Kulkarni GM; Vasireddy NR; Vandavasi JK; Dixit SS; Sharma V; Chattopadhyaya J
Bioorg Med Chem; 2009 Jul; 17(13):4681-92. PubMed ID: 19457676
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis.
Bhongade BA; Gouripur VV; Gadad AK
Bioorg Med Chem; 2005 Apr; 13(8):2773-82. PubMed ID: 15781388
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antitubercular evaluation and 3D-QSAR study of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives.
Khunt RC; Khedkar VM; Chawda RS; Chauhan NA; Parikh AR; Coutinho EC
Bioorg Med Chem Lett; 2012 Jan; 22(1):666-78. PubMed ID: 22104148
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR CoMFA of a series of DABO derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors.
de Brito MA; Rodrigues CR; Cirino JJ; de Alencastro RB; Castro HC; Albuquerque MG
J Chem Inf Model; 2008 Aug; 48(8):1706-15. PubMed ID: 18671385
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
20. 3D-QSAR study of 20 (S)-camptothecin analogs.
Lu AJ; Zhang ZS; Zheng MY; Zou HJ; Luo XM; Jiang HL
Acta Pharmacol Sin; 2007 Feb; 28(2):307-14. PubMed ID: 17241535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
